Biography
Ken Redekop, Ph.D. is an associate professor at the Institute for Medical Technology Assessment, Erasmus Universiteit Rotterdam, The Netherlands. He is a clinical epidemiologist with more than 20 years of experience in observational research, clinical trial analysis, and medical technology assessment and an author of over 100 papers in the medical literature. Current studies include early-stage cost-effectiveness analyses of medical devices and tests, RCT-based economic evaluations, economic evaluations in the Diagnostics Assessment programme of the National Institute for Health and Clinical Excellence (NICE, UK) and outcomes research studies to determine the effectiveness and cost-effectiveness of expensive medicines in daily practice. Most studies relate to diabetes, cardiovascular disease, and cancer, and most involve modelling and evidence synthesis.
Erasmus School of Health Policy & Management
- redekop@eshpm.eur.nl
More information
Work
- Carlos Antonio Godoy Junior, Laura Mäkitie, Eleonora Fiorenzato, Maija Koivu, Joonas Niskala, Angelo Antonini, Lytske Jantien Bakker, Luis Pilli, Carin Uyl-de Groot, William Ken Redekop & Welmoed Kirsten van Deen (2025) - - Journal of Parkinson's Disease, 1877718X251327752 - doi:
- Janneke W.C.M. Mulder, Annette M.H. Galema-Boers, Leonieke W. Kranenburg, Ken Redekop & Jeanine E. Roeters van Lennep (2025) - - Atherosclerosis, 401 - doi: -
- Erik H.M. Kemper, Hendrik Erenstein, Bart Jan Boverhof, Ken Redekop, Anna E. Andreychenko, Matthias Dietzel, Kevin B.W. Groot Lipman, Merel Huisman, Michail E. Klontzas, Frans Vos, Maarten IJzerman, Martijn P.A. Starmans & Jacob J. Visser (2024) - - European Radiology - doi: -
- Gimon de Graaf, Ivy Timmermans, Mathias Meine, Marco Alings, Susanne S Pedersen, Philippe Mabo, Edgar Zitron, Ken Redekop & Henneke Versteeg (2024) - - Journal of Telemedicine and Telecare, 30 (7), 1173-1185 - doi: -
- Bart Jan Boverhof, W. Ken Redekop, Jacob J. Visser, Carin A. Uyl-de Groot & Maureen P.M.H. Rutten-van Mölken (2024) - - Health Policy and Technology, 13 (2) - doi: -
- Carlos Antonio Godoy Junior, Francesco Miele, Laura Mäkitie, Eleonora Fiorenzato, Maija Koivu, Lytske Jantien Bakker, Carin A. Uyl-de Groot, William Ken Redekop & Welmoed Kirsten van Deen (2024) - - Patient, 17 (3), 275-285 - doi: -
- M. M.J. Galekop, J. Veldwijk, C. A. Uyl-de Groot & W. K. Redekop (2024) - - Food Quality and Preference, 113 - doi: -
- Milanne Maria Johanna Galekop, Josep Maria Del Bas, Philip C. Calder, Carin A. Uyl-De Groot & William Ken Redekop (2024) - - International Journal of Technology Assessment in Health Care, 40 (1) - doi: -
- Bart Jan Boverhof, W. Ken Redekop, Daniel Bos, Martijn P.A. Starmans, Judy Birch, Andrea Rockall & Jacob J. Visser (2024) - - Insights into Imaging, 15 (1) - doi: -
- Milanne Maria Johanna Galekop, Carin Uyl-de Groot & William Ken Redekop (2023) - - PharmacoEconomics - Open, 8 (2), 313-331 - doi: -
- Carin Uyl - de Groot, Ken Redekop, Amir Ansaripour, K. Zendehdel, N. Tadayon & F. Sadeghi (2016) - Use of data-mining to perform a real world cost analysis of HER2-positive breast cancer in Iran
